APO Research
Talk to an analyst

APO RESEARCH · REPORT

Geographic Atrophy Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Geographic Atrophy Drugs Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchGeographic Atrophy Drugs Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Geographic Atrophy Drugs Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Geographic Atrophy Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Geographic Atrophy Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Geographic Atrophy Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Geographic Atrophy Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Geographic Atrophy Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Geographic Atrophy Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Geographic Atrophy Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Geographic Atrophy Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Geographic Atrophy Drugs include Apellis Pharmaceuticals and Astellas Pharma etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Geographic Atrophy Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Geographic Atrophy Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Geographic Atrophy Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Geographic Atrophy Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Geographic Atrophy Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Geographic Atrophy Drugs sales, projected growth trends, production technology, application and end-user industry.

Geographic Atrophy Drugs Segment by Company

Apellis Pharmaceuticals

Astellas Pharma

Geographic Atrophy Drugs Segment by Type

Avacincaptad

Pegcetacoplan

Other

Geographic Atrophy Drugs Segment by Application

Hospital

Clinic

Other

Geographic Atrophy Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Geographic Atrophy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Geographic Atrophy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Geographic Atrophy Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Geographic Atrophy Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Geographic Atrophy Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Geographic Atrophy Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Geographic Atrophy Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Avacincaptad Major Manufacturers Table 3. Pegcetacoplan Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Geographic Atrophy Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Geographic Atrophy Drugs Industry Trends Table 10. Geographic Atrophy Drugs Industry Drivers Table 11. Geographic Atrophy Drugs Industry Opportunities and Challenges Table 12. Geographic Atrophy Drugs Industry Restraints Table 13. Global Geographic Atrophy Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Geographic Atrophy Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Geographic Atrophy Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Geographic Atrophy Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Geographic Atrophy Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Geographic Atrophy Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Geographic Atrophy Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Geographic Atrophy Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Geographic Atrophy Drugs Sales Market Share by Region (2021-2026) Table 22. Global Geographic Atrophy Drugs Sales Market Share by Region (2027-2032) Table 23. Global Geographic Atrophy Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Geographic Atrophy Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Geographic Atrophy Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Geographic Atrophy Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Geographic Atrophy Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Geographic Atrophy Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Geographic Atrophy Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Geographic Atrophy Drugs Manufacturers, Product Type & Application Table 31. Global Geographic Atrophy Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Geographic Atrophy Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Geographic Atrophy Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Geographic Atrophy Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Geographic Atrophy Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Geographic Atrophy Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Geographic Atrophy Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Geographic Atrophy Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Geographic Atrophy Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Geographic Atrophy Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Geographic Atrophy Drugs Sales Market Share by Type (2021-2026) Table 43. Global Geographic Atrophy Drugs Sales Market Share by Type (2027-2032) Table 44. Global Geographic Atrophy Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Geographic Atrophy Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Geographic Atrophy Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Geographic Atrophy Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Geographic Atrophy Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Geographic Atrophy Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Geographic Atrophy Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Geographic Atrophy Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Geographic Atrophy Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Geographic Atrophy Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Geographic Atrophy Drugs Sales Market Share by Application (2021-2026) Table 55. Global Geographic Atrophy Drugs Sales Market Share by Application (2027-2032) Table 56. Global Geographic Atrophy Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Geographic Atrophy Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Apellis Pharmaceuticals Company Information Table 59. Apellis Pharmaceuticals Business Overview Table 60. Apellis Pharmaceuticals Geographic Atrophy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Apellis Pharmaceuticals Geographic Atrophy Drugs Product Portfolio Table 62. Apellis Pharmaceuticals Recent Development Table 63. Astellas Pharma Company Information Table 64. Astellas Pharma Business Overview Table 65. Astellas Pharma Geographic Atrophy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Astellas Pharma Geographic Atrophy Drugs Product Portfolio Table 67. Astellas Pharma Recent Development Table 68. North America Geographic Atrophy Drugs Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Geographic Atrophy Drugs Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Geographic Atrophy Drugs Sales by Type (2021-2026) & (K Units) Table 71. North America Geographic Atrophy Drugs Sales by Type (2027-2032) & (K Units) Table 72. North America Geographic Atrophy Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America Geographic Atrophy Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America Geographic Atrophy Drugs Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Geographic Atrophy Drugs Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Geographic Atrophy Drugs Sales by Application (2021-2026) & (K Units) Table 77. North America Geographic Atrophy Drugs Sales by Application (2027-2032) & (K Units) Table 78. North America Geographic Atrophy Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America Geographic Atrophy Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Geographic Atrophy Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Geographic Atrophy Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 84. North America Geographic Atrophy Drugs Sales by Country (2021-2026) & (K Units) Table 85. North America Geographic Atrophy Drugs Sales by Country (2027-2032) & (K Units) Table 86. North America Geographic Atrophy Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America Geographic Atrophy Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 89. Canada Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 90. Mexico Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 91. Europe Geographic Atrophy Drugs Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Geographic Atrophy Drugs Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Geographic Atrophy Drugs Sales by Type (2021-2026) & (K Units) Table 94. Europe Geographic Atrophy Drugs Sales by Type (2027-2032) & (K Units) Table 95. Europe Geographic Atrophy Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 96. Europe Geographic Atrophy Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 97. Europe Geographic Atrophy Drugs Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Geographic Atrophy Drugs Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Geographic Atrophy Drugs Sales by Application (2021-2026) & (K Units) Table 100. Europe Geographic Atrophy Drugs Sales by Application (2027-2032) & (K Units) Table 101. Europe Geographic Atrophy Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 102. Europe Geographic Atrophy Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 103. Europe Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Geographic Atrophy Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Geographic Atrophy Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 107. Europe Geographic Atrophy Drugs Sales by Country (2021-2026) & (K Units) Table 108. Europe Geographic Atrophy Drugs Sales by Country (2027-2032) & (K Units) Table 109. Europe Geographic Atrophy Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 110. Europe Geographic Atrophy Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 111. Germany Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 112. France Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 113. U.K. Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 114. Italy Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 115. Russia Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 116. Spain Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 119. Sweden Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 120. Poland Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 121. China Geographic Atrophy Drugs Revenue by Type (2021-2026) & (US$ Million) Table 122. China Geographic Atrophy Drugs Revenue by Type (2027-2032) & (US$ Million) Table 123. China Geographic Atrophy Drugs Sales by Type (2021-2026) & (K Units) Table 124. China Geographic Atrophy Drugs Sales by Type (2027-2032) & (K Units) Table 125. China Geographic Atrophy Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 126. China Geographic Atrophy Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 127. China Geographic Atrophy Drugs Revenue by Application (2021-2026) & (US$ Million) Table 128. China Geographic Atrophy Drugs Revenue by Application (2027-2032) & (US$ Million) Table 129. China Geographic Atrophy Drugs Sales by Application (2021-2026) & (K Units) Table 130. China Geographic Atrophy Drugs Sales by Application (2027-2032) & (K Units) Table 131. China Geographic Atrophy Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 132. China Geographic Atrophy Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Asia Geographic Atrophy Drugs Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Geographic Atrophy Drugs Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Geographic Atrophy Drugs Sales by Type (2021-2026) & (K Units) Table 136. Asia Geographic Atrophy Drugs Sales by Type (2027-2032) & (K Units) Table 137. Asia Geographic Atrophy Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Asia Geographic Atrophy Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Asia Geographic Atrophy Drugs Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Geographic Atrophy Drugs Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Geographic Atrophy Drugs Sales by Application (2021-2026) & (K Units) Table 142. Asia Geographic Atrophy Drugs Sales by Application (2027-2032) & (K Units) Table 143. Asia Geographic Atrophy Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Asia Geographic Atrophy Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Geographic Atrophy Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Geographic Atrophy Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Asia Geographic Atrophy Drugs Sales by Country (2021-2026) & (K Units) Table 150. Asia Geographic Atrophy Drugs Sales by Country (2027-2032) & (K Units) Table 151. Asia Geographic Atrophy Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Asia Geographic Atrophy Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Japan Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 154. South Korea Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 155. India Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 156. Australia Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Geographic Atrophy Drugs Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Geographic Atrophy Drugs Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Geographic Atrophy Drugs Sales by Type (2021-2026) & (K Units) Table 162. SAMEA Geographic Atrophy Drugs Sales by Type (2027-2032) & (K Units) Table 163. SAMEA Geographic Atrophy Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 164. SAMEA Geographic Atrophy Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 165. SAMEA Geographic Atrophy Drugs Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Geographic Atrophy Drugs Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Geographic Atrophy Drugs Sales by Application (2021-2026) & (K Units) Table 168. SAMEA Geographic Atrophy Drugs Sales by Application (2027-2032) & (K Units) Table 169. SAMEA Geographic Atrophy Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 170. SAMEA Geographic Atrophy Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 171. SAMEA Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Geographic Atrophy Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Geographic Atrophy Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. SAMEA Geographic Atrophy Drugs Sales by Country (2021-2026) & (K Units) Table 176. SAMEA Geographic Atrophy Drugs Sales by Country (2027-2032) & (K Units) Table 177. SAMEA Geographic Atrophy Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 178. SAMEA Geographic Atrophy Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Brazil Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 180. Argentina Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 181. Chile Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 182. Colombia Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 183. Peru Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 185. Israel Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 186. UAE Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 187. Turkey Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 188. Iran Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 189. Egypt Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Geographic Atrophy Drugs Distributors List Table 193. Geographic Atrophy Drugs Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Geographic Atrophy Drugs Image Figure 2. Global Geographic Atrophy Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Geographic Atrophy Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Avacincaptad Image Figure 5. Pegcetacoplan Image Figure 6. Other Image Figure 7. Global Geographic Atrophy Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Geographic Atrophy Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Geographic Atrophy Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Geographic Atrophy Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Geographic Atrophy Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Geographic Atrophy Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Geographic Atrophy Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Geographic Atrophy Drugs Sales (2021-2032) & (K Units) Figure 18. Global Geographic Atrophy Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Geographic Atrophy Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Geographic Atrophy Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Geographic Atrophy Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Geographic Atrophy Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Geographic Atrophy Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Geographic Atrophy Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Geographic Atrophy Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Geographic Atrophy Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Geographic Atrophy Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Geographic Atrophy Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Geographic Atrophy Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Geographic Atrophy Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Geographic Atrophy Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Geographic Atrophy Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Geographic Atrophy Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Geographic Atrophy Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Geographic Atrophy Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Geographic Atrophy Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Geographic Atrophy Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Geographic Atrophy Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Geographic Atrophy Drugs Revenue Share by Type (2021-2032) Figure 41. North America Geographic Atrophy Drugs Sales Share by Type (2021-2032) Figure 42. North America Geographic Atrophy Drugs Revenue Share by Application (2021-2032) Figure 43. North America Geographic Atrophy Drugs Sales Share by Application (2021-2032) Figure 44. North America Geographic Atrophy Drugs Revenue Share by Country (2021-2032) Figure 45. North America Geographic Atrophy Drugs Sales Share by Country (2021-2032) Figure 46. Europe Geographic Atrophy Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Geographic Atrophy Drugs Sales Share by Type (2021-2032) Figure 48. Europe Geographic Atrophy Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Geographic Atrophy Drugs Sales Share by Application (2021-2032) Figure 50. Europe Geographic Atrophy Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Geographic Atrophy Drugs Sales Share by Country (2021-2032) Figure 52. China Geographic Atrophy Drugs Revenue Share by Type (2021-2032) Figure 53. China Geographic Atrophy Drugs Sales Share by Type (2021-2032) Figure 54. China Geographic Atrophy Drugs Revenue Share by Application (2021-2032) Figure 55. China Geographic Atrophy Drugs Sales Share by Application (2021-2032) Figure 56. Asia Geographic Atrophy Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Geographic Atrophy Drugs Sales Share by Type (2021-2032) Figure 58. Asia Geographic Atrophy Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Geographic Atrophy Drugs Sales Share by Application (2021-2032) Figure 60. Asia Geographic Atrophy Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Geographic Atrophy Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Geographic Atrophy Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Geographic Atrophy Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Geographic Atrophy Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Geographic Atrophy Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Geographic Atrophy Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Geographic Atrophy Drugs Sales Share by Country (2021-2032) Figure 68. Geographic Atrophy Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Geographic Atrophy Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Avacincaptad
  • Pegcetacoplan
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Apellis Pharmaceuticals
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Geographic Atrophy Drugs Market by Type
  3. 1.2.1 Global Geographic Atrophy Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Avacincaptad
  5. 1.2.3 Pegcetacoplan
  6. 1.2.4 Other
  7. 1.3 Geographic Atrophy Drugs Market by Application
  8. 1.3.1 Global Geographic Atrophy Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Geographic Atrophy Drugs Market Dynamics
  1. 2.1 Geographic Atrophy Drugs Industry Trends
  2. 2.2 Geographic Atrophy Drugs Industry Drivers
  3. 2.3 Geographic Atrophy Drugs Industry Opportunities and Challenges
  4. 2.4 Geographic Atrophy Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Geographic Atrophy Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Geographic Atrophy Drugs Revenue by Region
  3. 3.2.1 Global Geographic Atrophy Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Geographic Atrophy Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Geographic Atrophy Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Geographic Atrophy Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Geographic Atrophy Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Geographic Atrophy Drugs Sales by Region
  9. 3.4.1 Global Geographic Atrophy Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Geographic Atrophy Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Geographic Atrophy Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Geographic Atrophy Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Geographic Atrophy Drugs Revenue by Manufacturers
  2. 4.1.1 Global Geographic Atrophy Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Geographic Atrophy Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Geographic Atrophy Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Geographic Atrophy Drugs Sales by Manufacturers
  6. 4.2.1 Global Geographic Atrophy Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Geographic Atrophy Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Geographic Atrophy Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Geographic Atrophy Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Geographic Atrophy Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Geographic Atrophy Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Geographic Atrophy Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Geographic Atrophy Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Geographic Atrophy Drugs Market CR5 and HHI
  16. 4.8.2 2025 Geographic Atrophy Drugs Tier 1, Tier 2, and Tier 3
5 Geographic Atrophy Drugs Market by Type
  1. 5.1 Global Geographic Atrophy Drugs Revenue by Type
  2. 5.1.1 Global Geographic Atrophy Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Geographic Atrophy Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Geographic Atrophy Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Geographic Atrophy Drugs Sales by Type
  6. 5.2.1 Global Geographic Atrophy Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Geographic Atrophy Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Geographic Atrophy Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Geographic Atrophy Drugs Price by Type
6 Geographic Atrophy Drugs Market by Application
  1. 6.1 Global Geographic Atrophy Drugs Revenue by Application
  2. 6.1.1 Global Geographic Atrophy Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Geographic Atrophy Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Geographic Atrophy Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Geographic Atrophy Drugs Sales by Application
  6. 6.2.1 Global Geographic Atrophy Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Geographic Atrophy Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Geographic Atrophy Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Geographic Atrophy Drugs Price by Application
7 Company Profiles
  1. 7.1 Apellis Pharmaceuticals
  2. 7.1.1 Apellis Pharmaceuticals Company Information
  3. 7.1.2 Apellis Pharmaceuticals Business Overview
  4. 7.1.3 Apellis Pharmaceuticals Geographic Atrophy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Apellis Pharmaceuticals Geographic Atrophy Drugs Product Portfolio
  6. 7.1.5 Apellis Pharmaceuticals Recent Developments
  7. 7.2 Astellas Pharma
  8. 7.2.1 Astellas Pharma Company Information
  9. 7.2.2 Astellas Pharma Business Overview
  10. 7.2.3 Astellas Pharma Geographic Atrophy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Astellas Pharma Geographic Atrophy Drugs Product Portfolio
  12. 7.2.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America Geographic Atrophy Drugs Market Size by Type
  2. 8.1.1 North America Geographic Atrophy Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Geographic Atrophy Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Geographic Atrophy Drugs Price by Type (2021-2032)
  5. 8.2 North America Geographic Atrophy Drugs Market Size by Application
  6. 8.2.1 North America Geographic Atrophy Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Geographic Atrophy Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Geographic Atrophy Drugs Price by Application (2021-2032)
  9. 8.3 North America Geographic Atrophy Drugs Market Size by Country
  10. 8.3.1 North America Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Geographic Atrophy Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Geographic Atrophy Drugs Market Size by Type
  2. 9.1.1 Europe Geographic Atrophy Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Geographic Atrophy Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Geographic Atrophy Drugs Price by Type (2021-2032)
  5. 9.2 Europe Geographic Atrophy Drugs Market Size by Application
  6. 9.2.1 Europe Geographic Atrophy Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Geographic Atrophy Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Geographic Atrophy Drugs Price by Application (2021-2032)
  9. 9.3 Europe Geographic Atrophy Drugs Market Size by Country
  10. 9.3.1 Europe Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Geographic Atrophy Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Geographic Atrophy Drugs Market Size by Type
  2. 10.1.1 China Geographic Atrophy Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Geographic Atrophy Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Geographic Atrophy Drugs Price by Type (2021-2032)
  5. 10.2 China Geographic Atrophy Drugs Market Size by Application
  6. 10.2.1 China Geographic Atrophy Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Geographic Atrophy Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Geographic Atrophy Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Geographic Atrophy Drugs Market Size by Type
  2. 11.1.1 Asia Geographic Atrophy Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Geographic Atrophy Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Geographic Atrophy Drugs Price by Type (2021-2032)
  5. 11.2 Asia Geographic Atrophy Drugs Market Size by Application
  6. 11.2.1 Asia Geographic Atrophy Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Geographic Atrophy Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Geographic Atrophy Drugs Price by Application (2021-2032)
  9. 11.3 Asia Geographic Atrophy Drugs Market Size by Country
  10. 11.3.1 Asia Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Geographic Atrophy Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Geographic Atrophy Drugs Market Size by Type
  2. 12.1.1 SAMEA Geographic Atrophy Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Geographic Atrophy Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Geographic Atrophy Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Geographic Atrophy Drugs Market Size by Application
  6. 12.2.1 SAMEA Geographic Atrophy Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Geographic Atrophy Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Geographic Atrophy Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Geographic Atrophy Drugs Market Size by Country
  10. 12.3.1 SAMEA Geographic Atrophy Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Geographic Atrophy Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Geographic Atrophy Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Geographic Atrophy Drugs Value Chain Analysis
  2. 13.1.1 Geographic Atrophy Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Geographic Atrophy Drugs Production Mode & Process
  6. 13.2 Geographic Atrophy Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Geographic Atrophy Drugs Distributors
  9. 13.2.3 Geographic Atrophy Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst